Generic Valcyte is a deoxynucleoside analogue cytomegalovirus DNA polymerase inhibitor indicated for several conditions in pediatric and adult patients.
NCPA and NACDS are praising the U.S. House of Representatives’ Committee on Oversight and Accountability for launching an investigation into pharmacy benefit managers.
Together, the companies will cultivate innovative and evidence-based solutions to improve health outcomes in under-resourced and underserved communities.